Girach A, Aamir A, Zis P
The Medical School, University of Sheffield, Sheffield, UK.
University Hospitals of Leicester NHS Trust, Leicester, UK.
Drugs Today (Barc). 2019 Jul;55(7):469-476. doi: 10.1358/dot.2019.55.7.3010575.
The placebo effect is a phenomenon of great scientific interest that affects the response in both inactive and active treatments. It is broadly understood as the product of a central integration of positive expectations, reward learning and continuous conditioning inducing physiological changes in the brain. The placebo effect is accepted as a phenomenon which can be harnessed in clinical practice. It has emerged that there is not a single neurobiological mechanism involved in placebo responses, but many depending on the underlying disease. Molecular neuroimaging techniques with positron emission tomography and selective radiotracers have been significant in the understanding of the neurobiological systems involved in the placebo effect. The aim of this review was to summarize the key findings relating to the neurobiology behind the placebo effect.
安慰剂效应是一种极具科学研究价值的现象,它会影响无效治疗和有效治疗的反应。一般认为,它是积极期望、奖赏学习和持续条件作用在中枢整合的产物,会引起大脑的生理变化。安慰剂效应被认为是一种可在临床实践中加以利用的现象。现已发现,安慰剂反应并非由单一的神经生物学机制引起,而是取决于潜在疾病的多种机制。正电子发射断层扫描和选择性放射性示踪剂等分子神经成像技术,对于理解参与安慰剂效应的神经生物学系统具有重要意义。本综述的目的是总结与安慰剂效应背后的神经生物学相关的关键发现。